Phase 3 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who had little to no disability before their stroke (scoring 0–2 on a standard pre-stroke disability scale)
- People currently experiencing an acute ischemic stroke (a stroke caused by a blockage) that is considered moderate to severe based on a standard neurological assessment
- People whose stroke is caused by a blockage in a specific artery in the brain (the middle cerebral artery or internal carotid artery), confirmed by a CT or MRI scan, for which a procedure to remove the blockage is planned
- People treated within 24 hours of when they were last seen well — within 6 hours, a standard brain scan showing enough healthy brain tissue is required; between 6 and 24 hours (or if the time of stroke is unknown), specific advanced imaging must show a significant area of brain that is at risk but not yet damaged, meeting set size and ratio thresholds
- People who have or have not received a clot-dissolving drug (rtPA) given through a vein
Who may not be able to join:
- People with a nasal blockage that would prevent a nasal tube from being fully inserted
- People with a known serious bleeding disorder, or whose blood test results show very poor clotting (confirm with trial site for specific values)
- People who have had a brain injury or brain surgery/procedure within the last 3 months
- People with a serious active infection
- Women who are pregnant (women of childbearing age with a negative pregnancy test may still be considered eligible)
- People with a known condition causing inflammation of the blood vessels in the brain (cerebral vasculitis)
- People whose brain scan shows active bleeding (note: certain small, pre-existing spots seen on MRI may still be permitted — confirm with trial site)
- People with a known life expectancy of less than 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Juergen Bardutzky, Prof., University of Freiburg, Department of Neurology, Germany
Phone: +49-15237729739
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
functional outcome
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.